Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. / Meris, Alessandra; Amigoni, Maria; Uno, Hajime; Thune, Jens Jakob; Verma, Anil; Køber, Lars; Bourgoun, Mikhail; McMurray, John J; Velazquez, Eric J; Maggioni, Aldo P; Ghali, Jalal; Arnold, J Malcolm O; Zelenkofske, Steven; Pfeffer, Marc A; Solomon, Scott D.

In: European Heart Journal, Vol. 30, No. 1, 2009, p. 56-65.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Meris, A, Amigoni, M, Uno, H, Thune, JJ, Verma, A, Køber, L, Bourgoun, M, McMurray, JJ, Velazquez, EJ, Maggioni, AP, Ghali, J, Arnold, JMO, Zelenkofske, S, Pfeffer, MA & Solomon, SD 2009, 'Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study', European Heart Journal, vol. 30, no. 1, pp. 56-65. https://doi.org/10.1093/eurheartj/ehn499

APA

Meris, A., Amigoni, M., Uno, H., Thune, J. J., Verma, A., Køber, L., Bourgoun, M., McMurray, J. J., Velazquez, E. J., Maggioni, A. P., Ghali, J., Arnold, J. M. O., Zelenkofske, S., Pfeffer, M. A., & Solomon, S. D. (2009). Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. European Heart Journal, 30(1), 56-65. https://doi.org/10.1093/eurheartj/ehn499

Vancouver

Meris A, Amigoni M, Uno H, Thune JJ, Verma A, Køber L et al. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. European Heart Journal. 2009;30(1):56-65. https://doi.org/10.1093/eurheartj/ehn499

Author

Meris, Alessandra ; Amigoni, Maria ; Uno, Hajime ; Thune, Jens Jakob ; Verma, Anil ; Køber, Lars ; Bourgoun, Mikhail ; McMurray, John J ; Velazquez, Eric J ; Maggioni, Aldo P ; Ghali, Jalal ; Arnold, J Malcolm O ; Zelenkofske, Steven ; Pfeffer, Marc A ; Solomon, Scott D. / Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. In: European Heart Journal. 2009 ; Vol. 30, No. 1. pp. 56-65.

Bibtex

@article{039290e0117f11df803f000ea68e967b,
title = "Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study",
abstract = "AIMS: To assess the relationship between left atrial (LA) size and outcome after high-risk myocardial infarction (MI) and to study dynamic changes in LA size during long-term follow-up. METHODS AND RESULTS: The VALIANT Echocardiography study prospectively enrolled 610 patients with left ventricular (LV) dysfunction, heart failure (HF), or both following MI. We assessed LA volume indexed to body surface area (LAVi) at baseline, 1 month, and 20 months after MI. Baseline LAVi was an independent predictor of all-cause death or HF hospitalization (P = 0.004). In patients who survived to 20 months, LAVi increased a mean of 3.00 +/- 7.08 mL/m(2) from baseline. Hypertension, lower estimated glomerular filtration rate, and LV mass were the only baseline independent predictors of LA remodelling. Changes in LA size were related to worsening in MR and increasing in LV volumes. LA enlargement during the first month was significantly greater in patients who subsequently died or were hospitalized for HF than in patients without events. CONCLUSION: Baseline LA size is an independent predictor of death or HF hospitalization following high-risk MI. Moreover, LA remodelling during the first month after infarction is associated with adverse outcome.",
author = "Alessandra Meris and Maria Amigoni and Hajime Uno and Thune, {Jens Jakob} and Anil Verma and Lars K{\o}ber and Mikhail Bourgoun and McMurray, {John J} and Velazquez, {Eric J} and Maggioni, {Aldo P} and Jalal Ghali and Arnold, {J Malcolm O} and Steven Zelenkofske and Pfeffer, {Marc A} and Solomon, {Scott D}",
note = "Keywords: Aged; Atrial Function, Left; Echocardiography; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Atria; Heart Failure; Humans; Hypertension; Kaplan-Meiers Estimate; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Ventricular Dysfunction, Left",
year = "2009",
doi = "10.1093/eurheartj/ehn499",
language = "English",
volume = "30",
pages = "56--65",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "1",

}

RIS

TY - JOUR

T1 - Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study

AU - Meris, Alessandra

AU - Amigoni, Maria

AU - Uno, Hajime

AU - Thune, Jens Jakob

AU - Verma, Anil

AU - Køber, Lars

AU - Bourgoun, Mikhail

AU - McMurray, John J

AU - Velazquez, Eric J

AU - Maggioni, Aldo P

AU - Ghali, Jalal

AU - Arnold, J Malcolm O

AU - Zelenkofske, Steven

AU - Pfeffer, Marc A

AU - Solomon, Scott D

N1 - Keywords: Aged; Atrial Function, Left; Echocardiography; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Atria; Heart Failure; Humans; Hypertension; Kaplan-Meiers Estimate; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Ventricular Dysfunction, Left

PY - 2009

Y1 - 2009

N2 - AIMS: To assess the relationship between left atrial (LA) size and outcome after high-risk myocardial infarction (MI) and to study dynamic changes in LA size during long-term follow-up. METHODS AND RESULTS: The VALIANT Echocardiography study prospectively enrolled 610 patients with left ventricular (LV) dysfunction, heart failure (HF), or both following MI. We assessed LA volume indexed to body surface area (LAVi) at baseline, 1 month, and 20 months after MI. Baseline LAVi was an independent predictor of all-cause death or HF hospitalization (P = 0.004). In patients who survived to 20 months, LAVi increased a mean of 3.00 +/- 7.08 mL/m(2) from baseline. Hypertension, lower estimated glomerular filtration rate, and LV mass were the only baseline independent predictors of LA remodelling. Changes in LA size were related to worsening in MR and increasing in LV volumes. LA enlargement during the first month was significantly greater in patients who subsequently died or were hospitalized for HF than in patients without events. CONCLUSION: Baseline LA size is an independent predictor of death or HF hospitalization following high-risk MI. Moreover, LA remodelling during the first month after infarction is associated with adverse outcome.

AB - AIMS: To assess the relationship between left atrial (LA) size and outcome after high-risk myocardial infarction (MI) and to study dynamic changes in LA size during long-term follow-up. METHODS AND RESULTS: The VALIANT Echocardiography study prospectively enrolled 610 patients with left ventricular (LV) dysfunction, heart failure (HF), or both following MI. We assessed LA volume indexed to body surface area (LAVi) at baseline, 1 month, and 20 months after MI. Baseline LAVi was an independent predictor of all-cause death or HF hospitalization (P = 0.004). In patients who survived to 20 months, LAVi increased a mean of 3.00 +/- 7.08 mL/m(2) from baseline. Hypertension, lower estimated glomerular filtration rate, and LV mass were the only baseline independent predictors of LA remodelling. Changes in LA size were related to worsening in MR and increasing in LV volumes. LA enlargement during the first month was significantly greater in patients who subsequently died or were hospitalized for HF than in patients without events. CONCLUSION: Baseline LA size is an independent predictor of death or HF hospitalization following high-risk MI. Moreover, LA remodelling during the first month after infarction is associated with adverse outcome.

U2 - 10.1093/eurheartj/ehn499

DO - 10.1093/eurheartj/ehn499

M3 - Journal article

C2 - 19001474

VL - 30

SP - 56

EP - 65

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 1

ER -

ID: 17395141